市场调查报告书
商品编码
1209791
全球整容手术市场:到 2028 年的预测——手术类型(非侵入性、侵入性)、性别(女性、男性)、年龄组(13-29、30-54、55+)、最终用户分析、地区Cosmetic Surgery Market Forecasts to 2028 - Global Analysis By Procedure Type (Non-invasive Procedures and Invasive procedures), Gender (Female and Male), Age Group (13-29, 30-54 and 55 and above), End User and Geography |
根据 Stratistics MRC 的数据,全球整容手术市场规模将在 2022 年达到 568.5 亿美元,到 2028 年达到 792.9 亿美元,预测期内復合年增长率为 5.7%。
整容手术是指患者为修改、塑造轮廓或改善其外貌而进行的任何手术。 整容手术是医学的一个分支,专注于通过手术和药物治疗改善外观。 整容手术可以在头部、颈部或身体的任何部位进行。 整容手术是可选的,因为治疗区域缺乏正常功能和美感。 整容手术包括范围广泛的程序。
根据国际美容整形外科学会(ISAPS)2020年公布的数据,男性最常进行的手术大约有225,177次吸脂手术、905,958次肉毒桿菌毒素注射和298,070次脱毛手术。据悉,有
市场动态
驱动程序
越来越关注审美功能
近年来,随着美容成为日常生活的重要组成部分,美容手术的需求也逐渐发生变化。 越来越多的人开始关注审美特征,从而创造了潜在的商机。 女性对隆胸、吸脂、双眼皮、腹部整形等整容手术的偏好正在推动整容手术的市场需求。 出于多种原因,非手术治疗是首选,包括更快的恢復时间、更少的疼痛和更低的医疗费用。 除了上述因素外,主要公司加大研发投入和新产品推出也在推动市场扩张。
抑製剂
整容手术相关的并发症
整容手术期间和之后可能会出现各种问题。 在沙龙和水疗中心等非医疗环境中进行的非医生手术正在产生越来越多的问题。 疤痕、肿胀、感染和神经损伤是整容手术最常见的一些后果。 此外,使用面部填充物的副作用一直是限制市场扩张的主要障碍。 发红、皮肤色素沉着、瘀伤、歪斜的笑容、炎症反应和其他问题很普遍。 人们担心安全,这减少了接受整容手术的人数。 这是整容手术需求下降的主要原因之一。
机会
男性对整容手术的需求不断增长
由于年龄问题,美容治疗在男性人群中的普及和采用逐年增加,男性选择这些手术来保持年轻的容貌。 此外,男性对皮肤填充剂和肉毒桿菌毒素治疗等非手术程序的需求不断增长,这推动了执行程序的数量,促进了整个市场的发展。 这些变量,连同稳步改善的性别平衡,正在推动男性人群对整容手术的总需求。
威胁
混乱市场的存在
在各个国家/地区,提供整容手术的非法经销商数量不断增加,吸引了很大一部分希望进行整容手术的人。 此类设施,例如无执照的从业者和外科医生,正在对市场产生负面影响。 由于患者接受不合格的材料和植入物,这些方面导致越来越多的整容手术失败。 与无序市场相关的整容手术不良影响的发生越来越多,预计将在预测期内抑制整容手术市场的增长。
COVID-19 的影响
预计 COVID-19 疫情将对全球整容手术市场的增长产生不利影响。 许多诊所和医院已经重组,以增加 COVID-19 患者的医院容量。 由于 COVID-19 流行病而实施的封锁减少了流行病期间患者就诊整容手术的频率。 整容手术是一种非紧急手术,会对化妆品公司的盈利能力产生重大影响。 在过去的几个月里,人们对非侵入性手术的兴趣有所增加,而对侵入性手术的兴趣有所下降。
预计在预测期内非侵入性手术部分将是最大的部分
由于接受皮肤填充剂、肉毒桿菌毒素和透明质酸等非侵入性手术的患者越来越多,而且越来越多的患者越来越多,预计非侵入性手术部分将实现有利增长。 这种日益普及可能归因于它提供的几个好处,包括更快的恢復时间、更低的住院率和无痛治疗。 肉毒桿菌毒素注射、软组织填充剂、化学换肤和其他非侵入性手术很受欢迎。
预计在预测期内,医院和诊所部门的复合年增长率最高
由于整容手术的增加以及执行各种外科手术的医院和诊所的增加,预计医院和诊所部分在预测期内将呈现最快的复合年增长率。 与其他设施相比,医院和诊所进行大部分美容治疗。 此外,对微创手术的需求不断增加以及患者对诊所的偏好正在推动该行业的扩张。
市场份额最高的地区
由于执行各种美容手术的高素质整形外科医生以及美国和加拿大美容诊所的增加,预计北美在预测期内将占据最大的市场份额。 此外,先进的医疗基础设施、美容治疗的接受度、皮肤问题患病率上升以及获得董事会认证的专业美容外科医生的存在是推动该地区市场扩张的一些主要因素。
复合年增长率最高的地区
欧洲预计将在预测期内创下最高复合年增长率。 非侵入性治疗的日益普及以及在德国和法国等国家开设新的医疗水疗中心正在推动该地区的市场扩张。 技术先进的产品的可用性和对外观吸引力的日益重视可能会推动该地区的市场。
主要发展
2022 年 7 月,Cutera 宣布批准 AviClear,这是美国第一个也是唯一一个用于治疗轻度、中度和重度痤疮的激光治疗设备。
2022 年 6 月,Cynosure 推出了 PicoSure Pro,它具有由铂金製成的先进透镜聚焦阵列,据信可通过增加胶原蛋白和弹性蛋白含量来帮助缩小皱纹、痤疮疤痕和毛孔。设备“已经发布。
2021 年 2 月,Merz Pharma 宣布在美国推出 BELOTERO BALANCE+利多卡因。 BELOTERO BALANCE 是一种用于蚀刻线的透明质酸 (HA) 填充剂,由于利多卡因配方的好处,可为填充剂患者提供完美的表面处理。
2020年7月,Bosch Medical旗下的Solta Medical发布了一款射频紧肤仪——Thermage FLX系统。 Thermage FLX 是唯一获得 FDA 批准的眼睑治疗系统。
本报告的内容
免费定制服务
订阅此报告的客户将免费获得以下自定义选项之一。
According to Stratistics MRC, the Global Cosmetic Surgery Market is accounted for $56.85 billion in 2022 and is expected to reach $79.29 billion by 2028 growing at a CAGR of 5.7% during the forecast period. Cosmetic surgery is a voluntary operation that patients undergo in order to modify their bodies, contour their bodies, and improve their physical appearance. Cosmetic surgery is a distinct branch of medicine that focuses on improving appearance through surgical and medicinal treatments. Cosmetic surgery can be performed on any part of the head, neck, or body. Cosmetic surgery is optional because treated parts function normally but lack aesthetic appeal. Cosmetic surgery encompasses a wide range of procedures.
According to the data published by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, it was reported that around 225,177 liposuction, 905,958 botulinum toxin, and 298,070 hair removal were among the most common procedures performed on men.
Market Dynamics:
Driver:
Rising focus on aesthetic features
As beauty has become a significant component of daily life, the demand for cosmetic operations has gradually changed in recent years. The increase in population focusing on aesthetic characteristics has created potential business prospects. Women's preference for aesthetic procedures such as breast augmentation, liposuction, eyelid surgery, abdominoplasty, and others is driving up market demand for cosmetic procedures. People prefer non-surgical therapies for a variety of reasons, including shorter recovery times, less pain, and lower healthcare expenses. The factors listed above, as well as increased R&D investments and new product launches by key players, are driving and contributing to market expansion.
Restraint:
Complications associated with cosmetic procedure
A variety of issues may arise during or after the cosmetic surgery. Non-physician operations performed in salons, spas, and other non-medical environments are producing an increasing number of issues. Scars, swelling, infections, and nerve damage are some of the most common consequences of cosmetic operations. Furthermore, the adverse effects of utilising face fillers are a major barrier limiting market expansion. Redness, skin pigmentation, bruising, crooked smile, inflammatory reaction, and other problems are prevalent. People have safety concerns, which reduces the number of people who have cosmetic operations. This aspect has played a significant role in lowering the demand for cosmetic surgeries.
Opportunity:
Increasing demand for cosmetic procedures among male population
Because of age-related concerns, the popularity and adoption of cosmetic treatments among the male population is increasing year after year, and men are choosing these procedures to keep their youthful appearance. Furthermore, rising demand for nonsurgical procedures such as dermal fillers and botulinum toxin procedures among men is driving up the number of procedures performed and contributing to total market development. The aforementioned variables, as well as the steadily better gender balance, are increasing the total demand for cosmetic operations among the male population.
Threat:
Presence of an unregulated market
Various countries have seen an increase in the number of illegal sellers offering cosmetic operations and luring a sizable section of the population eager to undergo aesthetic procedures. These facilities, such as unlicensed medical practitioners and surgeons, have a negative impact on the market. This aspect contributes to an increase in the number of cosmetic procedures that go wrong, with patients accepting substandard materials and implants. Increasing incidences of undesirable effects of aesthetic surgery associated to an uncontrolled market are expected to restrain the growth of the cosmetic surgery market during the projected period.
COVID-19 Impact
The COVID-19 epidemic is expected to have a detrimental impact on the growth of the worldwide cosmetic surgery market. A number of clinics and hospitals were restructured in order to boost hospital capacity for COVID-19 patients. The implementation of lockdown due to the COVID-19 epidemic resulted in a decrease in the frequency of patient visits for aesthetic operations during the pandemic. Cosmetic surgical operations are non-emergency procedures that have considerably affected the profitability of aesthetic companies. Interest in non-invasive procedures has increased during the past few months while interest in invasive procedures has declined.
The non-invasive procedures segment is expected to be the largest during the forecast period
The non-invasive procedures segment is estimated to have a lucrative growth, due to the growing popularity and higher patient population undergoing non-invasive procedures such as dermal filler, botulinum toxin, hyaluronic acid, and others. This increased popularity can be attributed to the several advantages provided, such as shorter recovery times, lower hospitalisation rates, painless treatments, and more. Botox injections, soft tissue fillers, chemical peels, and other non-invasive procedures are popular.
The hospitals & clinic segment is expected to have the highest CAGR during the forecast period
The Hospitals & Clinic segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in number of cosmetic surgeries, and rise in number of hospitals and clinics to conduct various surgical procedures. In comparison to other facilities, hospitals and clinics execute the majority of cosmetic treatments. Furthermore, the increased demand for minimally invasive procedures, as well as patients' preference for clinics, is driving category expansion.
Region with highest share:
North America is projected to hold the largest market share during the forecast period owing to the presence of highly qualified plastic surgeons performing various cosmetic procedures and the growing number of aesthetic clinics in the U.S. and Canada. Furthermore, sophisticated healthcare infrastructure, cosmetic treatment acceptance, rising prevalence of skin problems, and the existence of board-certified and professional cosmetic surgeons in the region are some of the primary factors driving market expansion.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period. The growing popularity of noninvasive procedures, as well as the opening of new medical spas in countries such as Germany and France, is driving market expansion in this region. The availability of technologically sophisticated items, as well as the increased emphasis on physical attractiveness, is expected to drive the regional market.
Key players in the market
Some of the key players profiled in the Cosmetic Surgery Market include Syneron Candela, Solta Medical, AbbVie, Lumenis, Cynosure, Evolus, Inc., Galderma S.A., Bausch Health Companies Inc., Alma Lasers, MerzPharma GmbH & Co. KGaA, Johnson and Johnson, Apyx Medical
Key Developments:
In July 2022, Cutera announced the approval for AviClear, the first and only laser treatment device approved in the U.S. to cure mild, moderate, and severe acne.
In June 2022, Cynosure launched the PicoSure Pro Device, which has an advanced lens focus array made of Platinum which would help to reduce wrinkles, acne scars and pores by increasing the content of collagen and elastin.
In February 2021, Merz Pharma announced the launch of BELOTERO BALANCE + Lidocaine in the U.S. The BELOTERO BALANCE is a hyaluronic acid (HA) filler for etchedin lines & advantages of lidocaine formulation provides a perfect finish to filler patients.
In July 2020, Bausch Health Companies Inc.'s Solta Medical has released the radiofrequency device-Thermage FLX system, designed to tighten skin. Thermage FLX is the only FDA-approved system for the treatment of eyelids.
Procedure Types Covered:
Genders Covered:
Age Groups Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: